Loading…
Decoy Therapeutics Inc. is projected to decline to $3.78 by 2027, a -13% move from its current price of $4.34. DCOY is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $4.00 | $4.34 | $4.71 | -0.01% |
| Aug 6 | $3.87 | $4.34 | $4.86 | -0.02% |
| Aug 7 | $3.77 | $4.34 | $4.99 | -0.04% |
| Aug 8 | $3.69 | $4.34 | $5.10 | -0.05% |
| Aug 9 | $3.62 | $4.34 | $5.20 | -0.06% |
| Aug 10 | $3.56 | $4.34 | $5.29 | -0.07% |
| Aug 11 | $3.50 | $4.34 | $5.37 | -0.08% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.50 | $4.34 | $5.37 | -0.08% |
| Week 2 | $3.20 | $4.33 | $5.86 | -0.17% |
| Week 3 | $2.99 | $4.33 | $6.27 | -0.25% |
| Week 4 | $2.82 | $4.33 | $6.64 | -0.33% |
| Week 5 | $2.68 | $4.32 | $6.97 | -0.41% |
| Week 6 | $2.56 | $4.32 | $7.29 | -0.50% |
| Week 7 | $2.45 | $4.31 | $7.60 | -0.58% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Decoy Therapeutics Inc. is a pre-clinical stage biotechnology company that focuses on advancing peptide conjugate therapeutics through its IMP3ACT platform, which leverages peptide coiled-coils chemistry and physics to design a-helical peptides using computational and ML tools. The company aims to build a portfolio of peptide conjugate therapeutics addressing infectious diseases and oncology.
Formerly Salarius Pharmaceuticals, Inc., the company changed its name to Decoy Therapeutics Inc. in January 2026. Decoy Therapeutics is based in Houston, Texas, and sits within the Healthcare sector.
Decoy Therapeutics Inc. (DCOY) is the listed equity with a current price of $4.04 and a small-cap market position. It shows a market capitalization of $2.15M and is ranked 5188 by market size. The stock’s near-term price trajectory is mixed, with a flat-to-slightly-positive average around the current price and several year-by-year variations in the forecast.
The forecast suggests a neutral near-term path in 2026 with a 2026 avg of $4.04 and a max of $4.54, and a neutral outlook through 2029 before turning bullish toward 2030 and beyond. The longer-horizon view projects potential upside, with a 2030 avg of $5.20 and a 2050 avg of $11.18, signaling meaningful long-run appreciation despite short-run headwinds.
A major floor 13.8% below — a decisive break under it would weaken the trend.
The nearest floor, 13.8% below — buyers have tended to step in here.
The nearest ceiling, 121.0% above — a clean break opens room to run.
A major ceiling 168.7% above — clearing it would confirm fresh momentum.
Key DCOY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of DCOY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $3.97 | Buy | $4.16 | Buy |
| MA 10 | $4.50 | Sell | $4.51 | Sell |
| MA 20 | $5.33 | Sell | $5.08 | Sell |
| MA 50 | $6.23 | Sell | $5.81 | Sell |
| MA 100 | $6.22 | Sell | $8.35 | Sell |
| MA 200 | $11.23 | Sell | $31.20 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.49 | Neutral |
| Stoch RSI (14) | 31.23 | Neutral |
| CCI (20) | -98.01 | Neutral |
| Williams %R (14) | -84.84 | Info |
| MACD (12,26,9) | -0.15 | Sell |
| ROC (12) | -33.50 | Sell |
| Bollinger %B (20,2) | 0.19 | Neutral |
| Stochastic %K (14) | 15.16 | Buy |
| TRIX (15) | -1.14 | Sell |
| Awesome (5,34) | -1.86 | Sell |
| Ultimate (7,14,28) | 30.59 | Neutral |
| Momentum (10) | -1.50 | Sell |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 3.75 | Buy |
| ADX (14) | 18.51 | Neutral |
| ATR (14) | 0.38 | Info |
The 30-day technical snapshot is bearish, with RSI(14) at 30. The stock trades below both the 50-day simple moving average ($6.28) and the 200-day simple moving average ($12.38). Support sits at $3.74 and resistance at $9.59, defining a trading range that reflects cautious sentiment.
Over the past 30 days, the price has wandered between $2.26 and $7.23, highlighting notable volatility. Annualized volatility sits at 200%, underscoring the swing risk around the current price of $4.04.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.74 | $4.34 | $4.86 | 0% | Neutral | |
| $2.75 | $3.78 | $5.60 | -13% | Neutral | |
| $2.25 | $3.28 | $5.19 | -24% | Bearish | |
| $2.73 | $4.20 | $6.99 | -3% | Neutral | |
| $3.45 | $5.57 | $9.64 | +28% | Bullish | |
| $2.85 | $4.80 | $8.61 | +11% | Neutral | |
| $2.79 | $4.91 | $9.07 | +13% | Neutral | |
| $2.65 | $4.85 | $9.22 | +12% | Neutral | |
| $2.03 | $3.88 | $7.56 | -11% | Neutral | |
| $2.45 | $4.85 | $9.68 | +12% | Neutral | |
| $2.60 | $5.77 | $12.66 | +33% | Bullish | |
| $5.37 | $11.93 | $27.44 | +175% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $3.74 | $4.34 | $5.12 | +0.00% |
| September 2026 | $3.50 | $4.25 | $5.40 | -1.97% |
| October 2026 | $3.48 | $4.29 | $5.56 | +0.91% |
| November 2026 | $3.13 | $3.91 | $5.14 | -9.01% |
| December 2026 | $2.89 | $3.64 | $4.86 | -6.81% |
Click any year to see its month-by-month DCOY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The DCOY price prediction for 2026 points to an average of $4.34 (low $3.74, high $4.86) — a potential gain of 0% on today's $4.34. Price action looks broadly range-bound.
In 2027, DCOY is projected to trade between $2.75 and $5.60, averaging $3.78 — a potential decline of -13% from today's $4.34. That is -13% versus the projected 2026 average. A consolidation phase looks the most probable path here.
Decoy Therapeutics Inc.'s 2028 outlook centres on $3.28, within a $2.25 to $5.19 range. That is -13% versus the projected 2027 average. That marks a -24% change versus current levels. A cyclical pullback looks likely — prices rarely move in a straight line.
By 2029, DCOY could reach as high as $6.99, with a base case around $4.20 and support toward $2.73 — roughly -3% from $4.34. A consolidation phase looks the most probable path here.
Expect DCOY to range from $3.45 to $9.64 through 2030. The $5.57 average target implies a +28% move from current prices. That is up +32% on the projected 2029 average. Momentum favours further upside here.
The DCOY price prediction for 2031 points to an average of $4.80 (low $2.85, high $8.61) — a potential gain of +11% on today's $4.34. A consolidation phase looks the most probable path here.
In 2032, DCOY is projected to trade between $2.79 and $9.07, averaging $4.91 — a potential gain of +13% from today's $4.34. That is up +2% on the projected 2031 average. Price action looks broadly range-bound.
Decoy Therapeutics Inc.'s 2033 outlook centres on $4.85, within a $2.65 to $9.22 range. That is -1% versus the projected 2032 average. That marks a +12% change versus current levels. A consolidation phase looks the most probable path here.
By 2034, DCOY could reach as high as $7.56, with a base case around $3.88 and support toward $2.03 — roughly -11% from $4.34. Price action looks broadly range-bound.
Expect DCOY to range from $2.45 to $9.68 through 2035. The $4.85 average target implies a +12% move from current prices. That is up +25% on the projected 2034 average. A consolidation phase looks the most probable path here.
The DCOY price prediction for 2040 points to an average of $5.77 (low $2.60, high $12.66) — a potential gain of +33% on today's $4.34. Momentum favours further upside here.
In 2050, DCOY is projected to trade between $5.37 and $27.44, averaging $11.93 — a potential gain of +175% from today's $4.34. That is up +107% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in DCOY today (≈ 230.414747 DCOY) could be worth
$2,748.63
+$1,748.63 (+175%) by 2050 · US Dollar
Based on the average projected DCOY price of $11.93 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in DCOYwould be worth at today's price.
$1,000 invested in DCOY on Jul 31, 2025 (≈ 9.274717 DCOY) would be worth
$40.25
-$959.75 (-96.0%) today · 0.04× · US Dollar
Based on a DCOY entry price of $107.82 vs. today's $4.34.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.04 | $861.11 | -13.9% |
| 1 month ago | $7.62 | $569.55 | -43.0% |
| 3 months ago | $5.9 | $735.59 | -26.4% |
| 6 months ago | $8.64 | $502.31 | -49.8% |
| 1 year ago | $107.82 | $40.25 | -96.0% |
| All time (5.0y) ago | $28,908 | $0.15 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our DCOY forecast.
Our base-case forecast reaches $8.70 around 2050.
Implied market cap at $8.70: $4.63M
Looking further out, the year-by-year forecast contains periods of modest decline followed by longer-term upside. The 2030 forecast shows an avg price of $5.20 with a max of $9.01 and a min of $3.22, corresponding to a 28.7% ROI and a bullish tone. The 2040 forecast scales higher, with an avg of $5.31, a max of $11.64, and a 31.4% ROI, still labeled bullish.
In 2050 the model projects an avg of $11.18 and a max of $25.70, a 176.6% ROI, with bullish sentiment. These figures illustrate potential substantial long-run upside, but they are estimates and not guarantees. As a pre-clinical stage biotechnology company, the path forward involves substantial development risk and execution risk that could alter outcomes.
Tap a question to reveal the answer.
In 2030 the forecast shows an avg of $5.20, a min of $3.22, and a max of $9.01, with an ROI of 28.7% and bullish sentiment.
Near-term forecasts are mixed (neutral to bearish) through 2029, but the longer horizon shows bullish potential with 2030/2040/2050 averages of $5.20, $5.31, and $11.18 respectively, and highs up to $9.01, $11.64, and $25.70. These are estimates, not guarantees.
Yes, the 2030 max is $9.01, but the 2040 max is $11.64, and the 2050 max is $25.70, suggesting it could surpass $10 by 2040 according to the forecast.
Current price is $4.04 and market cap is $2.15M.
The 30-day range is between $2.26 and $7.23.
Decoy Therapeutics Inc. Community Discussion
0Share your Decoy Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.